文献速递肝胆胰外科

成人间活体肝移植的新基准:整合东西方经验

Novel Benchmark for Adult-to-Adult Living-donor Liver Transplantation: Integrating Eastern and Western Experiences.
PubMed 文献 · Ann Surg · 2023-07-21

该研究在3大洲15个高容量中心回顾5年成人间活体肝移植(LDLT)病例,定义基准病例并推导基准界值。3636例中1864例(51%)符合基准标准;基准界值在透析、原发无功能、非吻合口狭窄、移植物丢失和再移植方面低于尸肝移植基准,但胆漏、肝动脉血栓和CCI高于尸肝基准,死亡率相当。右半肝移植物CCI更低,亚洲中心结局更优。

要点

  • LDLT基准界值可作质量评估与比较工具,部分指标优于尸肝移植。
  • 右半肝移植物较左半肝CCI更低(34 vs 21,P<0.001)。
  • 亚洲中心在CCI、移植物丢失和再移植率上优于其他中心。

核心结论

  • 基准LDLT可减少等待list死亡率,但需全球经验交流、公众意识和集中化政策以实现基准结局。

研究设计与样本

  • 回顾性分析15个高容量中心(≥10例/年)来自3大洲5年(2016-2020)的成人间LDLT患者,最低随访1年。
  • 基准标准包括MELD≤20、无门静脉血栓、无既往重大腹部手术、无肾脏替代治疗、无急性肝衰竭、无ICU入住。
  • 基准界值取自所有中心中位数的第75百分位。

主要发现

  • 3636例中1864例(51%)符合基准病例。
  • 1年基准界值:移植后透析≤4%、原发无功能≤0.9%、非吻合口狭窄≤0.2%、移植物丢失≤7.7%、再移植≤3.6%,低于尸肝移植基准。
  • 胆漏≤12.4%、肝动脉血栓≤5.1%、CCI≤56高于尸肝移植基准,死亡率≤9.1%与尸肝移植相当。
  • 右半肝较左半肝CCI更低(34 vs 21,P<0.001);保留中肝静脉对受者和供者结局均无影响。
  • 亚洲中心较其他中心CCI更低(21 vs 47,P<0.001)、移植物丢失率更低(3.0% vs 6.5%,P=0.002)、再移植率更低(1.0% vs 2.5%,P=0.029)。

关键数值与推荐

  • 基准病例标准:MELD≤20、无门静脉血栓、无既往重大腹部手术、无肾脏替代治疗、无急性肝衰竭、无ICU入住。
  • 基准界值:移植后透析≤4%、原发无功能≤0.9%、非吻合口狭窄≤0.2%、移植物丢失≤7.7%、再移植≤3.6%、胆漏≤12.4%、肝动脉血栓≤5.1%、CCI≤56、死亡率≤9.1%。

临床怎么用

  • 可将基准界值用于LDLT受者质量评估和中心间比较。
  • 右半肝移植物可能降低CCI,保留中肝静脉不影响结局。
  • 低容量中心需通过经验交流和政策集中化改善结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To define benchmark values for adult-to-adult living-donor liver transplantation (LDLT). BACKGROUND: LDLT utilizes living-donor hemiliver grafts to expand the donor pool and reduce waitlist mortality. Although references have been established for donor hepatectomy, no such information exists for recipients to enable conclusive quality and comparative assessments. METHODS: Patients undergoing LDLT were analyzed in 15 high-volume centers (≥10 cases/year) from 3 continents over 5 years (2016-2020), with a minimum follow-up of 1 year. Benchmark criteria included a Model for End-stage Liver Disease ≤20, no portal vein thrombosis, no previous major abdominal surgery, no renal replacement therapy, no acute liver failure, and no intensive care unit admission. Benchmark cutoffs were derived from the 75th percentile of all centers' medians. RESULTS: Of 3636 patients, 1864 (51%) qualified as benchmark cases. Benchmark cutoffs, including posttransplant dialysis (≤4%), primary nonfunction (≤0.9%), nonanastomotic strictures (≤0.2%), graft loss (≤7.7%), and redo-liver transplantation (LT) (≤3.6%), at 1-year were below the deceased donor LT benchmarks. Bile leak (≤12.4%), hepatic artery thrombosis (≤5.1%), and Comprehensive Complication Index (CCI ® ) (≤56) were above the deceased donor LT benchmarks, whereas mortality (≤9.1%) was comparable. The right hemiliver graft, compared with the left, was associated with a lower CCI ® score (34 vs 21, P < 0.001). Preservation of the middle hepatic vein with the right hemiliver graft had no impact neither on the recipient nor on the donor outcome. Asian centers outperformed other centers with CCI ® score (21 vs 47, P < 0.001), graft loss (3.0% vs 6.5%, P = 0.002), and redo-LT rates (1.0% vs 2.5%, P = 0.029). In contrast, non-benchmark low-volume centers displayed inferior outcomes, such as bile leak (15.2%), hepatic artery thrombosis (15.2%), or redo-LT (6.5%). CONCLUSIONS: Benchmark LDLT offers a valuable alternative to reduce waitlist mortality. Exchange of expertise, public awareness, and centralization policy are, however, mandatory to achieve benchmark outcomes worldwide.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Li Z, Rammohan A, Gunasekaran V, et al. Novel Benchmark for Adult-to-Adult Living-donor Liver Transplantation: Integrating Eastern and Western Experiences. Ann Surg. 2023. PMID: 37477016. doi:10.1097/SLA.0000000000006038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。